Trademark: ACUREX 2207194
Word
ACUREX
ID
2207194
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
14 June 2021
Registration Date
14 June 2021
Renewal Date
14 June 2031
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of Parkinson's disease, Alzheimer's, ALS, huntington's, and diseases of aging; therapeutic agents for removal of damaged mitochondrial cells for medical purposes; medical diagnostic tests, biomarkers and assays for detection of Parkinson's disease, Alzheimer's, ALS, Huntington's, diseases of aging, and other mitochondrial diseases.
Pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of Parkinson's disease, Alzheimer's, ALS, huntington's, and diseases of aging; therapeutic agents for removal of damaged mitochondrial cells for medical purposes; medical diagnostic tests, biomarkers and assays for detection of Parkinson's disease, Alzheimer's, ALS, Huntington's, diseases of aging, and other mitochondrial diseases.
Class 42:
Pharmaceutical research and development services in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's disease, Alzheimer's, ALS, Huntington's, and diseases of aging; providing medical and scientific research and information in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's disease, Alzheimer's, ALS, Huntington's, and diseases of aging; diagnostic research and development services for drug discovery in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's, Alzheimer's, ALS, Huntington's, and diseases of aging.
Pharmaceutical research and development services in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's disease, Alzheimer's, ALS, Huntington's, and diseases of aging; providing medical and scientific research and information in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's disease, Alzheimer's, ALS, Huntington's, and diseases of aging; diagnostic research and development services for drug discovery in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's, Alzheimer's, ALS, Huntington's, and diseases of aging.